A detailed history of Cibc World Markets Corp transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 26,429 shares of CTKB stock, worth $88,272. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,429
Previous 11,358 132.69%
Holding current value
$88,272
Previous $73,000 43.84%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$4.0 - $7.26 $60,284 - $109,415
15,071 Added 132.69%
26,429 $105,000
Q4 2024

Feb 10, 2025

BUY
$4.7 - $7.4 $53,382 - $84,049
11,358 New
11,358 $73,000

Others Institutions Holding CTKB

About Cytek Biosciences, Inc.


  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $450M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Cibc World Markets Corp Portfolio

Follow Cibc World Markets Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.